Psychedelic Medicine – what does the future hold?

Prof David Castle

writer

Prof David Castle

Psychiatrist; Inaugural Scientific Director, Centre for Complex Interventions (CCI) at the Centre for Addictions and Mental Health (CAMH), Toronto, Canada; Professor, Department of Psychiatry, The University of Toronto Honorary Affiliation - Professor of Psychiatry at St Vincent’s Health and The University of Melbourne

Prof David Castle

Professor David Castle, Chair Psychiatry St Vincent’s Hospital and University of Melbourne and Board Director Mind Medicine Australia, answers some of the big questions about the re-emerging field of psychedelic-assisted psychotherapy in this Q&A.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

Bonomo Y, Norman A, Biondo S, Bruno R, Daglish M, Dawe S, et al. The Australian Drug Harms Ranking Study. J Psychopharmacol. 2019 Jul; 33(7): 759-68. DOI: 10.1177/0269881119841569

Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR. The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis. Psychiatry Res 2020 Feb; 284: 112749. DOI: 10.1016/j.psychres.2020.112749

Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, et al. Psilocybin-assisted therapy for depression: how do we advance the field? Aust N Z J Psychiatry. 2020 Mar; 54(3): 225-31. DOI: 10.1177/0004867419888575

Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, et al. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomised controlled trials. Psychopharmacology (Berl). 2019 Sep: 236(9): 2735-45. DOI: 10.1007/s00213-019-05249-5

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Kate Walsh

Dr Kate Walsh

Endometriosis Cases – Practical Guide

Prof Finlay Macrae AO

Prof Finlay Macrae AO

Familial Colorectal Cancer

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Terence O'Brien

Prof Terence O'Brien

SUDEP – What is it and How to Reduce the Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Prof David Castle

writer

Prof David Castle

Psychiatrist; Inaugural Scientific Director, Centre for Complex Interventions (CCI) at the Centre for Addictions and Mental Health (CAMH), Toronto, Canada; Professor, Department of Psychiatry, The University of Toronto Honorary Affiliation - Professor of Psychiatry at St Vincent’s Health and The University of Melbourne

Test your knowledge

Recent articles

Latest GP poll

AHPRA's new CEO says he is committed to improving how complaints are handled. How likely is this to succeed?

Likely to succeed

0%

Unlikely to succeed

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

We invite you to join the upcoming Healthed webcast where we will focus on working through the popular management myths and misperceptions in general practice with the aim of improving patient outcomes and quality of life.

Tuesday 19th August, 7pm AEST